Corcept Therapeutics, Inc. (CORT)
121.08
+2.54
(+2.14%)
USD |
NASDAQ |
Oct 09, 16:00
121.08
0.00 (0.00%)
After-Hours: 16:09
Corcept Therapeutics 30-Day Average Daily Volume : 1.436M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.436M |
| October 07, 2026 | 1.453M |
| October 06, 2026 | 1.464M |
| October 05, 2026 | 1.472M |
| October 02, 2026 | 1.460M |
| October 01, 2026 | 1.454M |
| September 30, 2026 | 1.454M |
| September 29, 2026 | 1.450M |
| September 28, 2026 | 1.436M |
| September 25, 2026 | 1.422M |
| September 24, 2026 | 1.420M |
| September 23, 2026 | 1.409M |
| September 22, 2026 | 1.405M |
| September 21, 2026 | 1.420M |
| September 18, 2026 | 1.401M |
| September 17, 2026 | 851812.9 |
| September 16, 2026 | 850586.7 |
| September 15, 2026 | 870499.1 |
| September 14, 2026 | 878165.1 |
| September 11, 2026 | 898516.5 |
| September 10, 2026 | 1.006M |
| September 09, 2026 | 1.035M |
| September 08, 2026 | 1.043M |
| September 04, 2026 | 1.055M |
| September 03, 2026 | 1.069M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.081M |
| September 01, 2026 | 1.095M |
| August 31, 2026 | 1.086M |
| August 28, 2026 | 1.118M |
| August 27, 2026 | 1.151M |
| August 26, 2026 | 1.159M |
| August 25, 2026 | 1.160M |
| August 24, 2026 | 1.166M |
| August 21, 2026 | 1.176M |
| August 20, 2026 | 1.192M |
| August 19, 2026 | 1.206M |
| August 18, 2026 | 1.211M |
| August 17, 2026 | 1.223M |
| August 14, 2026 | 1.244M |
| August 13, 2026 | 1.245M |
| August 12, 2026 | 1.255M |
| August 11, 2026 | 1.258M |
| August 10, 2026 | 1.263M |
| August 07, 2026 | 1.275M |
| August 06, 2026 | 1.286M |
| August 05, 2026 | 1.285M |
| August 04, 2026 | 1.289M |
| August 03, 2026 | 1.276M |
| July 31, 2026 | 1.282M |
| July 30, 2026 | 1.249M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Eli Lilly & Co. | 2.348M |
| Pfizer Inc. | 33.11M |
| Aclaris Therapeutics, Inc. | 3.362M |
| Bristol Myers Squibb Co. | 11.23M |
| Liquidia Corp. | 3.525M |